Company / PP&E (Net)
Imunon, Inc. PP&E (Net) History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$751.9K
FY2023
5-year range
$294.6K / $751.9K
FY2019-FY2023
Trend
+37.1%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has increased for 3 consecutive years, from $294,551 in FY2020 to $751,906 in FY2023.
Based on SEC 10-K filings.
$751,906 in FY2023 with a 5-year CAGR of +32.4%.
Improved from $477,011 to $751,906 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +36.7%
- 5-Year CAGR
- +32.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Imunon, Inc.'s pp&e (net) has grown for 3 consecutive years.
- 5-year CAGR of +32.4%, indicating consistent growth.
- In FY2023, pp&e (net) increased 37.1% year-over-year.
- Peak pp&e (net) was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2023 | $751.9K | +37.1% |
| FY2022 | $548.3K | +14.9% |
| FY2021 | $477.0K | +61.9% |
| FY2020 | $294.6K | -27.3% |
| FY2019 | $405.4K | +119.6% |
| FY2018 | $184.6K | -78.4% |
| FY2015 | $854.9K | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026